Literature DB >> 26360128

Biological activities and pharmacokinetics of aconitine, benzoylaconine, and aconine after oral administration in rats.

Hai Zhang1,2, Sen Sun1, Wen Zhang1, Xiangqun Xie3, Zhenyu Zhu2, Yifeng Chai2, Guoqing Zhang1.   

Abstract

Aconitine (AC), benzoylaconine (BAC), and aconine (ACN) are three representative alkaloids in Aconitum tubers. Knowing that the drug disposal process in vivo is closely related to the toxicity and efficacy of a drug, it is important to classify the disposal properties of these alkaloids. In this study, the pharmacokinetics of the three alkaloids was investigated. The results showed that the three alkaloids could be quickly absorbed, especially BAC, whose Tmax was 0.31 ± 0.17 h. Their Cmax was 10.99, 3.99, and 4.29 ng·mL(-1) respectively, indicating that AC had better absorption than BAC and ACN. Subsequently, we further investigated their absorption mechanism using the Caco-2 cell monolayer model in vitro. The results showed that they were poorly absorbed, and the absorption of AC and BAC was inhibited by P-gp, while the absorption of ACN was in a form of passive diffusion. The t1/2 of AC, BAC and ACN was 1.41, 9.49, and 3.32 h, respectively, indicating that the metabolic or excretion rate of AC was quicker than that of BAC and ACN. Therefore, their metabolic stability was further investigated by using rat liver microsomes in vitro, which showed that AC was easier to be metabolized than BAC and ACN. The excretion experiments showed that AC and ACN were primarily excreted in urine, while BAC was excreted in faeces. In addition, the results of tissue distribution experiments showed that the three alkaloids distributed throughout all the organs, although the distribution rate of AC was slower than that of BAC and ACN.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS/MS; absorption; alkaloids; metabolic rate; pharmacokinetics

Mesh:

Substances:

Year:  2015        PMID: 26360128     DOI: 10.1002/dta.1858

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  5 in total

Review 1.  Relationships between the Toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the Toxicokinetics of Its Main Diester-Diterpenoid Alkaloids.

Authors:  Mengbi Yang; Xiaoyu Ji; Zhong Zuo
Journal:  Toxins (Basel)       Date:  2018-09-26       Impact factor: 4.546

2.  Simultaneous Evaluation of the Influence of Panax ginseng on the Pharmacokinetics of Three Diester Alkaloids after Oral Administration of Aconiti Lateralis Radix in Rats Using UHPLC/QQQ-MS/MS.

Authors:  Liang Yang; Yuguang Wang; Guangyao Huang; Jian Li; Zhaoyan Zhang; Zengchun Ma; Yue Gao
Journal:  Evid Based Complement Alternat Med       Date:  2018-12-09       Impact factor: 2.629

3.  An Intentional Aconite Overdose: A Case Report.

Authors:  Christopher Wood; James Coulson; John Thompson; Stephen Bonner
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-05-06

4.  A Novel Modulator of the Renin-Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation.

Authors:  Qi-Qiang Zhang; Feng-Hua Chen; Fei Wang; Xue-Mei Di; Wei Li; Hai Zhang
Journal:  Front Pharmacol       Date:  2022-03-11       Impact factor: 5.810

5.  Benzoylaconine improves mitochondrial function in oxygen-glucose deprivation and reperfusion-induced cardiomyocyte injury by activation of the AMPK/PGC-1 axis.

Authors:  Leijie Chen; Laixing Yan; Weiwei Zhang
Journal:  Korean J Physiol Pharmacol       Date:  2022-09-01       Impact factor: 1.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.